drugset / Trial / NCT03217175

Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise

NCT03217175

Terminated 22 enrolled Massachusetts General Hospital
RandomizedCrossoverSingle-blindTreatment

Summary

The study will consist of two study arms. Each arm will include a 24-96 hour outpatient run-in period prior to their exercise visit wearing the bi-hormonal bionic pancreas. In random order subjects will then complete two approximately 5-hour exercise visits, one wearing the bi-hormonal bionic pancreas and one wearing the insulin-only bionic pancreas.

Timeline

Start
2017-08-18
Primary completion
2018-03-09
Completion
2018-03-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glucagon Peptide